Published in:
01-05-2014 | Breast Oncology
Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer
Authors:
Rachel A. Greenup, MD, MPH, Jeffrey Peppercorn, MD, MPH, Mathias Worni, MD, MHS, E. Shelley Hwang, MD, MPH
Published in:
Annals of Surgical Oncology
|
Issue 5/2014
Login to get access
Excerpt
Over $125 billion is spent annually in the United States for cancer treatment.
1 Among women in this country, breast cancer remains the most common nondermatologic cancer diagnosis and the second leading cause of cancer-related death. In 2010, breast cancer treatment costs were estimated at $16.5 billion, comprising 13 % of the burden of total cancer-related costs.
2,
3 Health care spending varies throughout the phases of breast cancer treatment, with ~23 % of total expenditures allocated during the initial episode of treatment (diagnosis and management during the first year), 41 % during continuing care, and 36 % during the last year of life.
3,
4 It has been estimated that surgical costs account for 25 % of breast cancer treatment expenditure among Medicare patients.
5 …
